Related Experiment Video
Updated: Jan 31, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Discovery and characterization of a positive allosteric modulator of transient receptor potential canonical 6 (TRPC6)
S Häfner1, N Urban1, M Schaefer1
1Rudolf-Boehm-Institute of Pharmacology and Toxicology, Medical Faculty, Leipzig University, Härtelstraße 16-18, 04107 Leipzig, Germany.
Abstract:
The non-selective second messenger-gated cation channel TRPC6 (transient receptor potential canonical 6) is activated by diacylglycerols (DAG) in a PKC-independent manner and plays important roles in a variety of physiological processes and diseases. In order to facilitate novel therapies, the development of potent inhibitors as well as channel-activating agents is of great interest. The screening of a chemical library, comprising about 17,000 small molecule compounds, revealed an agent, which induced increases in intracellular Ca2+ concentrations ([Ca2+]i) in a concentration-dependent manner (EC50 = 2.37 ± 0.25 μM) in stably TRPC6-expressing HEK293 cells. This new compound (C20) selectively acts on TRPC6, unlike OAG (1-oleoyl-1-acetyl-sn-glycerol), which also activates PKC and does not discriminate between TRPC6 and the closely related channels TRPC3 and TRPC7. Further evaluation by Ca2+ assays and electrophysiological studies revealed that C20 rather operated as an enhancer of channel activation than as an activator by itself and led to the assumption that the compound C20 is an allosteric modulator of TRPC6, enabling low basal concentrations of DAG to induce activation of the ion channel. Furthermore, C20 was tested in human platelets that express TRPC6. A combined activation of TRPC6 with C20 and OAG elicited a robust increase in [Ca2+]i in human platelets. This potentiated channel activation was sensitive to TRPC6 channel blockers. To achieve sufficient amounts of C20 for biological studies, we applied a one-pot synthesis strategy. With regard to studies in native systems, the sensitizing ability of C20 can be a valuable pharmacological tool to selectively exaggerate TRPC6-dependent signals.
Insights
A novel compound, C20, selectively enhances TRPC6 channel activity by acting as an allosteric modulator. This discovery offers a new tool for studying TRPC6-dependent signaling pathways and developing targeted therapies.
Area of Science:
- Ion channel pharmacology
- Molecular and cellular biology
- Drug discovery
Background:
- Transient receptor potential canonical 6 (TRPC6) channels are crucial ion channels involved in various physiological and pathological processes.
- Developing selective modulators for TRPC6 is essential for understanding its function and for therapeutic interventions.
- Existing activators like OAG lack selectivity and can activate other TRPC channels and pathways.
Purpose of the Study:
- To identify and characterize novel small molecules that modulate TRPC6 channel activity.
- To investigate the mechanism of action of a newly identified TRPC6 modulator.
- To evaluate the utility of the compound in native systems like human platelets.
Main Methods:
- High-throughput screening of a chemical library to identify TRPC6 modulators.
- Calcium imaging assays (Ca2+ assays) to measure intracellular calcium levels.
- Electrophysiological studies to assess channel function.
- Synthesis of the identified compound (C20) using a one-pot strategy.
Main Results:
- A novel compound, C20, was identified that selectively enhances TRPC6 channel activity with an EC50 of 2.37 μM.
- C20 acts as an allosteric modulator, sensitizing TRPC6 to low concentrations of diacylglycerols (DAG) rather than directly activating it.
- C20 potentiated TRPC6-mediated calcium influx in human platelets when combined with OAG, demonstrating its efficacy in a native system.
- The compound's effects were confirmed to be TRPC6-specific and sensitive to TRPC6 blockers.
Conclusions:
- C20 is a valuable pharmacological tool that selectively enhances TRPC6 channel activation.
- Its allosteric modulatory mechanism provides a novel approach to targeting TRPC6.
- C20 holds promise for further research into TRPC6-dependent signaling and the development of new therapeutic strategies.
Related Concept Videos
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Allosteric Regulation
Internal Receptors

